CN1686293A - Paste preparation for treating oxide lichen and its preparation technology - Google Patents

Paste preparation for treating oxide lichen and its preparation technology Download PDF

Info

Publication number
CN1686293A
CN1686293A CN 200510041830 CN200510041830A CN1686293A CN 1686293 A CN1686293 A CN 1686293A CN 200510041830 CN200510041830 CN 200510041830 CN 200510041830 A CN200510041830 A CN 200510041830A CN 1686293 A CN1686293 A CN 1686293A
Authority
CN
China
Prior art keywords
fine powder
grams
unguentum
psoriasis
vaseline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510041830
Other languages
Chinese (zh)
Other versions
CN1298347C (en
Inventor
刘朝辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB200510041830XA priority Critical patent/CN1298347C/en
Publication of CN1686293A publication Critical patent/CN1686293A/en
Application granted granted Critical
Publication of CN1298347C publication Critical patent/CN1298347C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A medicine in the form of ointment for treating psoriasis is prepared from 3 chemical drugs including chlorpheniramine, etc and 4 Chinese-medicinal materials including realger, borneol, etc through pulverizing and mixing with vaseline.

Description

Treatment psoriasis unguentum and preparation technology thereof
Affiliated technical field:
The present invention treats the psoriasis unguentum and preparation technology belongs to dermopathic medicine of treatment and preparation technology thereof, relates in particular to topical drug and technology thereof with the treatment ringworm of Chinese medicine and chemical drugs mixed preparing.
Background technology:
Psoriasis is a kind of chronic dermatosis of common easy recurrence, being covered with silvery white squama with erythema is main clinic symptoms, also claim psoriasis or psoriasis, damage and be erythema, pimple is distributed in extremity mostly and stretches side and scalp position, conscious have a gargalesthesia, psoriasis belongs to the traditional Chinese medical science " in vain " category, and Chinese medical discrimination is divided into blood-heat syndrome, syndrome of blood stasis, syndrome of deficiency of blood is just sent out or is recurred soon, the skin lesion development rapidly, common pimple, maculopapule, the patch that differs in size, mottle is red, is covered with silvery white squama, with pruritus in various degree, after the course of disease was long, skin lesion was thick hard, is the speckle shape, color is dark red, with the passing of time the state of an illness delays again, and skin lesion is attenuation again, often is general whole body of patch shape or skin lesion, light red or the light brown of color, the cause of disease generates from epiderm skin and forms obstacle, automatic control effect damaged, and epidermis cell generates disorderly, pathogenesis has four aspects: the one, and wind and cold, wind heat, the heresy of pathogenic wind-warm is outer attacks, and causes battalion to defend and becomes estranged; The 2nd, internal injury caused by excess of seven emotions, obstruction of QI or eating and drinking without temperance, taste are become estranged, consequently strongly fragrant heat-transformation of a specified duration of functional activity of QI being not smooth, and heat is gone into nutrient blood, then consumes essence for a long time and hinders liquid, and the blood liquid drier is withered, failure of skin and muscle to be nourished; The 3rd, stasis of blood resistance skin disharmony between QI and blood; The 4th, deficiency of the liver and kindey, disharmony of Chong and Conception Channels.Relevant nothing more than, blood stasis dry and deficiency of the liver and kindey etc. with wind, heat, wet, cold, heat in blood, blood, it is numerous that existing market is sold the antipsoriatics thing, be painted with the master outward with chemicals, the Chinese herb compound oral formulations is also arranged, also have the microorganism oral formulations, can not coordinate to treat the defective high with relapse rate but all deposit in vivo with external.
Summary of the invention:
The objective of the invention is: provide scientific formulation to the psoriatic, the Chinese medicine for the treatment of both the principal and secondary aspects of a disease, itch, the effect of dispersing swelling and dissipating binds, the hemopoietic of putting on flesh, with " treatment psoriasis pure Chinese medicine capsule " and the usefulness of my development, can effectively treat dissimilar psoriasiss, and not recur.
In order to realize the foregoing invention purpose, the technology used in the present invention route is: treatment psoriasis unguentum is according to the main etiology and pathogenesis of psoriasis skin lesion, to kill tinea bacterium, scrubbing evacuation of pus, granulation promoting is antipruritic, the skin moistening that nourishes blood is a principle of treatment, raw material is by 20 of Realgar 5 grams, Borneolum Syntheticum 5 grams, Indigo Naturalis 15 grams, Rhizoma Coptidis 12 grams, prednisoni acetas sheet, 30 of chlorpheniramine maleate tabletses, the vaseline composition of 20 and 2 times crude drug weight of Co-trimoxazole Tablet in the prescription.Compound method is divided into Chinese crude drug and chemical tablet crushing screening powder process medicine and powder medicine and base material and grinds well and make unguentum twice technology, at first take by weighing Realgar by formula ratio, Borneolum Syntheticum, Indigo Naturalis, Rhizoma Coptidis four flavor Chinese crude drugs, being ground into fine powder respectively crosses 80 mesh sieves and becomes the fine powder medicine standby, get 20 of every prednisoni acetas sheets that contains prednisoni acetas 5mg more respectively, 30 of every chlorpheniramine maleate tabletses that contains chlorphenamine 4mg, every sulfamethoxazole 0.4 gram, 20 of the Co-trimoxazole Tablet of metopycide 0.08 gram mix porphyrize to be crossed 80 mesh sieves and becomes the fine powder medicine standby, at last various fine powder medicines are mixed the heavy vaseline of back and 2 times of amounts grind well unguentum.Though modern medicine thinks that blood deficiency in psoriasis and the body, blood are dry, heat in blood, wind, heat, wet, cold, deficiency of the liver and kindey, hypoimmunity are relevant, but external skin lesion place prolongs living directly related with antibacterial, fungus, in treatment psoriasis unguentum, Realgar has antibacterial action, various skin funguses such as trichophyton there is in various degree antibacterial and killing action, have the effect of bright poison, parasite killing, dampness and scrubbing evacuation of pus, dispersing swelling and dissipating binds, cure mainly insane cellulitis furuncle, scabies, eczema of lower limb; Borneolum Syntheticum has antiinflammatory, antibiotic, the refreshment of having one's ideas straightened out, granulation promoting analgesic effect, cures mainly that rheumatism is gathered, calentura coma, aphtha, carbuncle, hemorrhoid; Indigo Naturalis has stronger bacteriostasis to seven dermatophytes such as microsporum canis, trichophyton tonsurans, purple tinea bacterium, has anti-inflammation, the effect of heat-clearing and toxic substances removing, the liver pathogenic fire purging that disappears, and it is swollen to cure mainly epidemic febrile disease maculopapulae due to toxic heat, bleb; Rhizoma Coptidis is inhibitory action to multiple gram positive bacteria and multiple tinea bacterium, has clearing away heat-fire, dampness, detoxifies, puts on flesh, hemostasia effect, cures mainly pathopyretic ulcer, furunculosis septicemia, swelling of the vulva, eczema; The prednisoni acetas sheet has the antiallergic effect, is mainly used in the treatment lupus erythematosus, anaphylaxis illness such as serious dermatitis, and chlorpheniramine maleate tablets belongs to antihistaminic, and anti-allergic effects is strong, and toxic and side effects is little, is used for stiff reaction, is applicable to the sick treatment of various skin; Co-trimoxazole Tablet belongs to the sulfonamides antibiosis anti-inflammatory drug, contained sulfamethoxazole (SVZ) is a Trimethoprim, has very wide antibacterial activity, can make potentiation reach 10 times with the sulfa drugs use in conjunction, contained trimethoxy card ammonia phonetic noisy (TMP) is broad spectrum antimicrobicide, its antimicrobial spectrum is similar to sulfa drugs, Co-trimoxazole Tablet with being that SMZ has suppressed dioxy folic acid synzyme, make it not synthesize dioxy folic acid to amino benzoic Acid and dioxy pteridine, TMP has then further suppressed dihydrofolate reductase, make it not be reduced into four oxygen folic acid to dioxyacetic acid, by the dual continuous metabolism of blocking antibacterial, make antibacterial can not synthesize necessary ribonic acid of its life and desoxyribose, reach antibiotic sterilization effect.Each pharmaceutically active ingredient is played altogether and is killed tinea bacterium, scrubbing evacuation of pus, antipruritic, the skin moistening effect that nourishes blood of granulation promoting in one in prescription, with " treatment psoriasis pure Chinese medicine capsule " outer being coated with for oral administration of my invention, treating both the principal and secondary aspects of a disease, effectively cure psoriasis, and do not recur, treatment psoriasis unguentum preparation technology only adopts fine powder medicine and base material porphyrize paste manufacture process, preparation technology is easy, low production cost, this unguentum is a medicine for external use, is applied to skin and decreases the affected part, changed in three days and be coated with once, be coated with convenient.
The invention has the beneficial effects as follows: the scientific formulation novelty, preparation technology is easy, and low production cost is coated with convenient, and therapy of combining Chinese and Western medicine has the tinea of killing bacterium, scrubbing evacuation of pus, antipruritic, the skin moistening effect that nourishes blood of granulation promoting, can effectively cure psoriasis, and not recur.
Specific embodiments:
1, takes by weighing Realgar, Borneolum Syntheticum, Indigo Naturalis, Rhizoma Coptidis four flavor Chinese crude drugs with the existing decoction pieces standard of Chinese crude drug by formula ratio, be ground into fine powder respectively and cross 80 mesh sieves and become Chinese medicine fine powder medicine standby.
2, purchase the prednisoni acetas sheet with chemical drugs standard in the prescription, chlorpheniramine maleate tablets, bright tablet of three kinds of chemical drugss of compound recipe promise are crossed 80 mesh sieves by formula ratio mixing porphyrize and are become chemical medicine fine powder standby.
3, it is standby to take by weighing vaseline with 2 times of prescription medicinal raw material (four flavor Chinese crude drug and three kinds of chemical medicines) gross weights.
4, get part vaseline and add whole Chinese medicine fine powder medicines and chemical medicine fine powder medicine grinds to uniform and smooth, add residue vaseline again and grind well in fusion below 50 ℃, in the container of packing into unguentum.

Claims (2)

1, a kind of treatment psoriasis unguentum is characterized in that: raw material is by 20 of Realgar 5 grams, Borneolum Syntheticum 5 grams, Indigo Naturalis 15 grams, Rhizoma Coptidis 12 grams, prednisoni acetas sheet, 30 of chlorpheniramine maleate tabletses, the vaseline composition of 20 and 2 times crude drug weight of Co-trimoxazole Tablet in the prescription.
2, treat the preparation technology of psoriasis unguentum according to claim 1, it is characterized in that: at first take by weighing Realgar by formula ratio, Borneolum Syntheticum, Indigo Naturalis, Rhizoma Coptidis four flavor Chinese crude drugs, being ground into fine powder respectively crosses 80 mesh sieves and becomes the fine powder medicine standby, get 20 of every prednisoni acetas sheets that contains prednisoni acetas 5mg more respectively, 30 of every chlorpheniramine maleate tabletses that contains chlorphenamine 4mg, 20 of every Co-trimoxazole Tablet that contains sulfamethoxazole 0.4 gram and metopycide 0.08 gram, mix porphyrize and cross 80 mesh sieves and become the fine powder medicine standby, at last various fine powder medicines are mixed the heavy vaseline of back and 2 times of amounts grind well unguentum.
CNB200510041830XA 2005-03-23 2005-03-23 Paste preparation for treating oxide lichen and its preparation technology Expired - Fee Related CN1298347C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB200510041830XA CN1298347C (en) 2005-03-23 2005-03-23 Paste preparation for treating oxide lichen and its preparation technology

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB200510041830XA CN1298347C (en) 2005-03-23 2005-03-23 Paste preparation for treating oxide lichen and its preparation technology

Publications (2)

Publication Number Publication Date
CN1686293A true CN1686293A (en) 2005-10-26
CN1298347C CN1298347C (en) 2007-02-07

Family

ID=35304335

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB200510041830XA Expired - Fee Related CN1298347C (en) 2005-03-23 2005-03-23 Paste preparation for treating oxide lichen and its preparation technology

Country Status (1)

Country Link
CN (1) CN1298347C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102319285A (en) * 2011-08-08 2012-01-18 李熙东 External medicament for treating psoriasis and preparation method thereof
CN102716156A (en) * 2012-06-22 2012-10-10 吴长宇 External sterilization antiphlogistine formula and method for preparing antiphlogistine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1090492C (en) * 2000-03-30 2002-09-11 朱江 Ointment for treating skin tinea
CN1212130C (en) * 2001-07-19 2005-07-27 贾海燕 Medicine for treating psoriasis, ichthyosis and eczema

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102319285A (en) * 2011-08-08 2012-01-18 李熙东 External medicament for treating psoriasis and preparation method thereof
CN102319285B (en) * 2011-08-08 2013-03-13 李熙东 External medicament for treating psoriasis and preparation method thereof
CN102716156A (en) * 2012-06-22 2012-10-10 吴长宇 External sterilization antiphlogistine formula and method for preparing antiphlogistine

Also Published As

Publication number Publication date
CN1298347C (en) 2007-02-07

Similar Documents

Publication Publication Date Title
Bedi et al. Herbal therapy in dermatology
CN101874809A (en) Local anti-inflammatory external medicinal composition using glycerol DMSO mixed solvent
CN102068617B (en) Pure Chinese herbal medicine inflammation-diminishing and sterilizing suspension liniment and preparation method thereof
CN1298347C (en) Paste preparation for treating oxide lichen and its preparation technology
CN102240353A (en) Traditional Chinese drug anesthetic and preparation method thereof
CN1709302A (en) Chinese medicine formulation for treating chronic pelvic inflammation and its preparing method
CN1562142A (en) Chinese medicinal gels for treating vaginitis, cervicitis and cervical erosion and its preparing method
CN103520262B (en) A kind of lipid soluble gynecological gel
CN102100886A (en) Technology and method for preparing novel combined formulation of relieving-edema decoction
CN102416065A (en) Chinese medicinal embrocation for treating acnes
CN102846767A (en) Preparation process of integration-type novel formulation of MAXINGGANSHI decoction and production method thereof
CN101543616A (en) Traditional Chinese medicine composition for preventing and treating tumor and its preparation method
CN101332286B (en) Traditional Chinese medicine composition for treating skin disease and preparation method thereof
CN1224406C (en) Medical ointment Jiaoxuanxiao for treating beriberi
CN100352449C (en) Medicament composition for treating tinea pedis and tinea corporis
CN101940585B (en) Composite using orientin-2'-O-beta-L-galactoside as main component and application thereof
CN102526647A (en) Preparation technology and production method of novel dual-purpose decoction integrated dosage form
CN1449800A (en) Traditional Chinese medicine for treating wind-cold type of common cold and preparation process thereof
CN1895518A (en) Medicine for treating beriberi
CN102370937B (en) Traditional Chinese drug composition for treating breast benign hyperplasia diseases, and preparation method thereof
CN101264077B (en) Lignans and its use for preparing antiphlogistic antiendotoxin medicaments
CN101912595B (en) Ginger-bile medicament for treating cough and asthma
Punia et al. FORMULATION AND EVALUATION OF ANTIMICROBIAL TRANSDERMAL PATCH BY USING AZADIRACHTA INDICA AND CURCUMIN
CN1293051A (en) Liquid medicine for treating rhinitis
CN1065137C (en) Liniment made of traditional Chinese medicine for treating pharyngitis, and prepn. method therefor

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070207

Termination date: 20100323